First-In-Class Phase 2a Study Of Anb020 (Anti-Il-33) In The Treatment Of Moderate-To-Severe Atopic Dermatitis Y Chen,D Gutowska-Owsiak, M Westmoreland,T Mackenzie,L Cifuentes, A Lloyd-Lavery, A Marquette, B Kenney, M Londei,G OggALLERGY（2018）引用 2|浏览8暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
